-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca shares fell 2% due to disappointing phase III clinical trial results.

Zhitongcaijing·09/11/2026 20:25:09
Listen to the news
AstraZeneca shares fell 2% due to disappointing phase III clinical trial results.